JAMA ophthalmology
-
Randomized Controlled Trial
Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial.
Adding a laser-induced chorioretinal anastomosis (L-CRA) to current treatments for central retinal vein occlusion (CRVO) may improve outcomes and lessen therapy burdens. ⋯ For macular edema caused by CRVO, an L-CRA significantly reduced the number of ranibizumab injections required.